Copeptin: a neuroendocrine biomarker of COVID-19 severity
Sign Up to like & getrecommendations! Published in 2022 at "Biomarkers in Medicine"
DOI: 10.2217/bmm-2021-1100
Abstract: Aim: To investigate the change in a serum level of copeptin, a neuroendocrine biomarker, in differentiating grades of COVID-19 severity on admission time and to find its diagnostic potential. Materials & Methods: 160 COVID-19 patients… read more here.
Keywords: neuroendocrine biomarker; covid severity; copeptin neuroendocrine; serum copeptin ... See more keywords